(Q54284569)

27 May 2018

title

Adrenergic modulation of extrarenal potassium disposal in men with end-stage renal disease (English)

1 reference

23 October 2022

1 reference

23 October 2022

author name string

M. Allon

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1662320

23 October 2022

N. Shanklin

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1662320

23 October 2022

language of work or name

English

0 references

publication date

1 December 1991

1 reference

27 May 2018

full work available at URL

https://api.elsevier.com/content/article/PII:S0085253815574115?httpAccept=text/xml

1 reference

https://api.elsevier.com/content/article/PII:S0085253815574115?httpAccept=text/plain

23 October 2022

1 reference

23 October 2022

1 reference

27 May 2018

volume

40

1 reference

27 May 2018

issue

6

1 reference

27 May 2018

page(s)

1103-1109

1 reference

27 May 2018

https://scigraph.springernature.com/pub.10.1038/ki.1991.321

exact match

0 references

cites work

The Role of Adrenal Medullary Catecholamines in Potassium Homoeostasis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.321

7 January 2021

Extrarenal potassium homeostasis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.321

7 January 2021

Hypokalemia from Beta2-Receptor Stimulation by Circulating Epinephrine

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.321

7 January 2021

Adrenergic Modulation of Extrarenal Potassium Disposal

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.321

7 January 2021

Adrenaline causes hypokalaemia in man by beta 2 adrenoceptor stimulation

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.321

7 January 2021

The effects of cardioselective and non-selective beta-adrenoceptor blockade on the hypokalaemic and cardiovascular responses to adrenomedullary hormones in man.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.321

7 January 2021

Epinephrine and potassium homeostasis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.321

7 January 2021

Metabolic effects of salbutamol: comparison of aerosol and intravenous administration

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.321

7 January 2021

Hypokalaemia induced by inhalation of fenoterol

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.321

7 January 2021

Impairment of beta 2-adrenoceptor-stimulated potassium uptake in end-stage renal disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.321

7 January 2021

Potassium-lowering effect of albuterol for hyperkalemia in renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.321

7 January 2021

Treatment of hyperkalaemia in renal failure: salbutamol v. insulin

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.321

7 January 2021

Nebulized albuterol for acute hyperkalemia in patients on hemodialysis.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.321

7 January 2021

Albuterol and insulin for treatment of hyperkalemia in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.321

7 January 2021

Effect of various therapeutic approaches on plasma potassium and major regulating factors in terminal renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.321

7 January 2021

Control of serum potassium during fasting in patients with end-stage renal disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.321

7 January 2021

Impairment of extrarenal potassium disposal by alpha-adrenergic stimulation

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.321

7 January 2021

Catecholamine modulation of rapid potassium shifts during exercise

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.321

7 January 2021

Mechanisms of autonomic nervous system dysfunction in uremia

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.321

7 January 2021

Norepinephrine-related mechanism in hypertension accompanying renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.321

7 January 2021

Plasma free, sulfo- and glucuro-conjugated catecholamines in uremic patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.321

7 January 2021

Impaired regulation of beta 2-adrenergic receptor density in mononuclear cells during chronic renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.321

7 January 2021

Insulin resistance of uremia

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.321

7 January 2021

Adrenergic Mechanisms for the Effects of Epinephrine on Glucose Production and Clearance in Man

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.321

7 January 2021

Epinephrine is a hypophosphatemic hormone in man. Physiological effects of circulating epinephrine on plasma calcium, magnesium, phosphorus, parathyroid hormone, and calcitonin

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.321

7 January 2021

Beta-adrenergic-mediated extrarenal potassium disposal in patients with end-stage renal disease: effect of propranolol

series ordinal

20

1 reference

23 October 2022

Identifiers

DOI

10.1038/KI.1991.321

1 reference

27 May 2018

Dimensions Publication ID

1025810192

0 references

1 reference

27 May 2018